(Q34449238)

2 August 2017

The use of labetalol in Japan: results of multicentre clinical trials (English)

1 reference

multicenter clinical trial

2 August 2017

0 references

author name string

Takeda T

1

1 reference

2 August 2017

Kaneko Y

2

1 reference

2 August 2017

Omae T

3

1 reference

2 August 2017

Yoshinaga K

4

1 reference

2 August 2017

Masuyama Y

5

1 reference

2 August 2017

Nukada T

6

1 reference

2 August 2017

Shigiya R

7

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 June 1982

1 reference

British Journal of Clinical Pharmacology

2 August 2017

1 reference

2 August 2017

13

1 reference

2 August 2017

1 Suppl

1 reference

2 August 2017

49S-57S

1 reference

Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401838

Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401838

Effects of labetalol and propranolol on histamine-induced bronchoconstriction in normal subjects

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401838

Labetalol in the treatment of a patient with phaechromocytoma: a case report

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401838

Alpha and beta adrenergic blockade with orally administered labetalol in hypertension. Studies on blood volume, plasma renin and aldosterone and catecholamine excretion

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401838

Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401838

The effects of oral AH 5158, a combined α and β-adrenoceptor antagonist, in healthy volunteers

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1982.TB01889.X

Some haemodynamic effects of compound AH 5158 compared with propranolol, propranolol plus hydrallazine, and diazoxide: the use of AH 5158 in the treatment of hypertension

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7046774

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1365-2125.1982.TB01889.X

1 reference

2 August 2017

1 reference

2 August 2017

1 reference